These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18497530)

  • 1. Subretinal hemorrhages secondary to age-related macular degeneration: psychological and vision-related functional perspectives.
    Mozaffarieh M; Sacu S; Benesch T; Wedrich A
    Ophthalmologica; 2008; 222(3):199-204. PubMed ID: 18497530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S; Chow DR; Packo KH; MacCumber MW; Awh CC
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
    Krepler K; Kruger A; Tittl M; Stur M; Wedrich A
    Retina; 2000; 20(3):251-6. PubMed ID: 10872929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas.
    Hesse L; Kroll P
    Adv Ther; 1997; 14(5):275-80. PubMed ID: 10174620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S; Mahieu L; Lequeux L; Quintyn JC; Pagot-Mathis V
    J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
    Hassan AS; Johnson MW; Schneiderman TE; Regillo CD; Tornambe PE; Poliner LS; Blodi BA; Elner SG
    Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
    Schulze SD; Hesse L
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):717-20. PubMed ID: 12271367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.
    Fang IM; Lin YC; Yang CH; Yang CM; Chen MS
    Eye (Lond); 2009 Feb; 23(2):397-406. PubMed ID: 17975562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
    Hay SR; Madonna RJ
    Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration.
    Ron Y; Ehrlich R; Axer-Siegel R; Rosenblatt I; Weinberger D
    Ophthalmologica; 2007; 221(1):57-61. PubMed ID: 17183203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
    Cahill MT; Banks AD; Stinnett SS; Toth CA
    Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-patient management and treatment satisfaction after intravitreous plasminogen activator injection.
    Mozaffarieh M; Heinzl H; Sacu S; Wedrich A
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1421-8. PubMed ID: 16596407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of subretinal macular hemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas].
    Oficjalska-Młyńczak J; Zajac-Pytrus H; Marek J; Nizankowska MH
    Klin Oczna; 2003; 105(3-4):140-6. PubMed ID: 14552171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical results of intravitreal administration of tissue-type plasminogen activator (tPA) and gas for removal of subretinal hemorrhage in senile macular degeneration].
    Framme C; Toukhy HE; Sachs HG; Spiegel D; Roider J; Gabel VP; Lohmann CP
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):33-9. PubMed ID: 10702940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results.
    Hudson HL; Lane SS; Heier JS; Stulting RD; Singerman L; Lichter PR; Sternberg P; Chang DF;
    Ophthalmology; 2006 Nov; 113(11):1987-2001. PubMed ID: 16989902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative use of tissue plasminogen activator for large submacular hemorrhage.
    Chaudhry NA; Mieler WF; Han DP; Alfaro VD; Liggett PE
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):176-80. PubMed ID: 10100249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration.
    Fine HF; Iranmanesh R; Del Priore LV; Barile GR; Chang LK; Chang S; Schiff WM
    Retina; 2010; 30(10):1588-94. PubMed ID: 20856172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
    Ratanasukon M; Kittantong A
    Eye (Lond); 2005 Dec; 19(12):1328-32. PubMed ID: 15565185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
    de Jong JH; van Zeeburg EJ; Cereda MG; van Velthoven ME; Faridpooya K; Vermeer KA; van Meurs JC
    Retina; 2016 May; 36(5):914-25. PubMed ID: 26807631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.